Legislative Priorities


The Pancreatic Cancer Action Network calls on the 114th Congress to give current and future pancreatic cancer patients a fighting chance by:

  • Provide $5.26 billion for the National Cancer Institute (NCI) for fiscal year 2015
  • Continue to include pancreatic cancer in the Department of Defense (DoD) Peer-Reviewed Cancer Research Program (PRCRP), and provide the Senate-approved funding level of $50 million for the program
  • Join the Congressional Caucus on the Deadliest Cancers

The Problem: Pancreatic Cancer Deaths are Up and Federal Research Funding is in Jeopardy
Statistically, only 6 percent of pancreatic cancer patients survive more than five years. Even more alarming? The threat of pancreatic cancer is growing – it is predicted to surpass breast and colon cancer to become the second leading cause of cancer-related deaths by 2020. 

We must increase funding for the NIH (National Institutes of Health) and the NCI. These budgets have been cut repeatedly over the last few years. In fact, since fiscal year 2003, the NIH budget has decreased over 20 percent, more than $6 billion (adjusted for inflation). If we don’t stop sequestration, NIH may face more cuts in fiscal year 2016. Further, the NCI’s share of the NIH budget has declined, from 18.7 percent in the late 1990s to 16.4 percent today – a loss of $680 million. This situation cannot be allowed to continue. Our investment in cancer research must be increased.

There is some good news: Since 2011, pancreatic cancer has been included in the DoD’s PRCRP, which funds high-risk, high-reward research projects. As a result, more than $6.5 million in grants have been awarded for pancreatic cancer research projects. We ask Congress to support the Senate-approved funding level of $50 million for the program in FY15.

The Progress: NCI Has a Strategy to Advance Pancreatic Cancer Research
In February 2014, the NCI took a critical step in fulfilling the provisions of the Recalcitrant Cancer Research Act when it unveiled the “Scientific Framework for Pancreatic Ductal Adenocarcinoma,” providing specific recommendations for four specific research initiatives to develop early-detection methods and new treatment approaches.

With this report and the strategic direction it provides, it is critical that Congress ensure that NCI has sufficient resources to leverage these opportunities.

The Solution: Step Up Federal Research Funding
We call on Congress to stomp on pancreatic cancer by making cancer research funding a priority. For more information on pancreatic cancer and research funding, click on the buttons below.




Pancreatic cancer is the ONLY major cancer with a five-year survival rate still in the single digits at just 6%.  With your help, we can change this deadly statistic.